Mirvaso (Brimonidine Tartrate)

Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Use MIRVASO topical once per day, unless your doctor tells you otherwise.

Apply a pea-sized amount of this medicine to each affected area of the face (forehead, nose, chin, and each cheek). Try not to get any of the medicine near your eyes or on your lips.

Do not use this medicine on open wounds or on sunburned, windburned, dry, chapped, or irritated skin.

Wash your hands after applying this medicine.

Store at room temperature away from moisture and heat.

Keep this medicine out of the reach of children. MIRVASO topical can cause serious medical problems in a child who accidentally swallows the medicine. Seek emergency medical attention if this happens.

An overdose of MIRVASO topical is not expected to be dangerous. Seek emergency medical attention or call the Poison Help line if anyone has accidentally swallowed the medication.

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using MIRVASO topical and call your doctor at once if you have:

• severe skin redness, burning, or other irritation.

Common side effects may include:

• mild skin redness or burning;
• flushing (warmth, redness, or tingly feeling).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

You should not use this medicine if you are allergic to brimonidine.

To make sure MIRVASO topical is safe for you, tell your doctor if you have:

• coronary artery disease or circulation problems;
• heart disease or a blood vessel disorder;
• Raynaud's syndrome (numbness or cold feeling in your hands or feet);
• depression;
• low blood pressure;
• an autoimmune disorder called Sjogren's syndrome;
• a build-up of scar tissue on your skin (scleroderma); or
• if you take a heart or blood pressure medication.

FDA pregnancy category B. MIRVASO topical is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known whether MIRVASO topical passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine.

Do not take by mouth. MIRVASO topical is for use only on the skin of your face. Avoid getting this medicine in your eyes or mouth.

It is not likely that other drugs you take orally or inject will have an effect on topically applied MIRVASO. But many drugs can interact with each other. Tell each of your health care providers about all medicines you use, including prescription and over-the-counter medicines, vitamins, and herbal products.